These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 21597893

  • 1. Detection, classification, and characterization of focal liver lesions: Value of diffusion-weighted MR imaging, gadoxetic acid-enhanced MR imaging and the combination of both methods.
    Holzapfel K, Eiber MJ, Fingerle AA, Bruegel M, Rummeny EJ, Gaa J.
    Abdom Imaging; 2012 Feb; 37(1):74-82. PubMed ID: 21597893
    [Abstract] [Full Text] [Related]

  • 2. Detection of liver malignancy with gadoxetic acid-enhanced MRI: is addition of diffusion-weighted MRI beneficial?
    Kim YK, Kim CS, Han YM, Lee YH.
    Clin Radiol; 2011 Jun; 66(6):489-96. PubMed ID: 21367403
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic accuracy and sensitivity of diffusion-weighted and of gadoxetic acid-enhanced 3-T MR imaging alone or in combination in the detection of small liver metastasis (≤ 1.5 cm in diameter).
    Kim YK, Lee MW, Lee WJ, Kim SH, Rhim H, Lim JH, Choi D, Kim YS, Jang KM, Lee SJ, Lim HK.
    Invest Radiol; 2012 Mar; 47(3):159-66. PubMed ID: 22330426
    [Abstract] [Full Text] [Related]

  • 4. Detection and characterization of small focal hepatic lesions (≤2.5 cm in diameter): a comparison of diffusion-weighted images before and after administration of gadoxetic acid disodium at 3.0T.
    Song KD, Kim YK, Lee WJ, Lee MW, Park MJ, Hwang J, Lee MH.
    Acta Radiol; 2012 Jun 01; 53(5):485-93. PubMed ID: 22535883
    [Abstract] [Full Text] [Related]

  • 5. Comparison of gadoxetic acid-enhanced dynamic imaging and diffusion-weighted imaging for the preoperative evaluation of colorectal liver metastases.
    Chung WS, Kim MJ, Chung YE, Kim YE, Park MS, Choi JY, Kim KW.
    J Magn Reson Imaging; 2011 Aug 01; 34(2):345-53. PubMed ID: 21702068
    [Abstract] [Full Text] [Related]

  • 6. Detection of hepatocellular carcinoma in gadoxetic acid-enhanced MRI and diffusion-weighted MRI with respect to the severity of liver cirrhosis.
    Kim AY, Kim YK, Lee MW, Park MJ, Hwang J, Lee MH, Lee JW.
    Acta Radiol; 2012 Oct 01; 53(8):830-8. PubMed ID: 22847903
    [Abstract] [Full Text] [Related]

  • 7. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
    Xu PJ, Yan FH, Wang JH, Lin J, Ji Y.
    J Magn Reson Imaging; 2009 Feb 01; 29(2):341-9. PubMed ID: 19161186
    [Abstract] [Full Text] [Related]

  • 8. Small hepatocellular carcinomas: improved sensitivity by combining gadoxetic acid-enhanced and diffusion-weighted MR imaging patterns.
    Park MJ, Kim YK, Lee MW, Lee WJ, Kim YS, Kim SH, Choi D, Rhim H.
    Radiology; 2012 Sep 01; 264(3):761-70. PubMed ID: 22843769
    [Abstract] [Full Text] [Related]

  • 9. Detection of small hepatocellular carcinoma using gadoxetic acid-enhanced MRI: Is the addition of diffusion-weighted MRI at 3.0T beneficial?
    Zhao XT, Li WX, Chai WM, Chen KM.
    J Dig Dis; 2014 Mar 01; 15(3):137-45. PubMed ID: 24354621
    [Abstract] [Full Text] [Related]

  • 10. Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging.
    Parikh T, Drew SJ, Lee VS, Wong S, Hecht EM, Babb JS, Taouli B.
    Radiology; 2008 Mar 01; 246(3):812-22. PubMed ID: 18223123
    [Abstract] [Full Text] [Related]

  • 11. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.
    Motosugi U, Ichikawa T, Sou H, Sano K, Tominaga L, Muhi A, Araki T.
    Radiology; 2010 Jul 01; 256(1):151-8. PubMed ID: 20574092
    [Abstract] [Full Text] [Related]

  • 12. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
    Sun HY, Lee JM, Shin CI, Lee DH, Moon SK, Kim KW, Han JK, Choi BI.
    Invest Radiol; 2010 Feb 01; 45(2):96-103. PubMed ID: 20057319
    [Abstract] [Full Text] [Related]

  • 13. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ, Yan FH, Wang JH, Shan Y, Ji Y, Chen CZ.
    J Comput Assist Tomogr; 2010 Jul 01; 34(4):506-12. PubMed ID: 20657216
    [Abstract] [Full Text] [Related]

  • 14. Hilar cholangiocarcinoma: value of adding DW imaging to gadoxetic acid-enhanced MR imaging with MR cholangiopancreatography for preoperative evaluation.
    Park MJ, Kim YK, Lim S, Rhim H, Lee WJ.
    Radiology; 2014 Mar 01; 270(3):768-76. PubMed ID: 24475800
    [Abstract] [Full Text] [Related]

  • 15. Incremental value of liver MR imaging in patients with potentially curable colorectal hepatic metastasis detected at CT: a prospective comparison of diffusion-weighted imaging, gadoxetic acid-enhanced MR imaging, and a combination of both MR techniques.
    Kim HJ, Lee SS, Byun JH, Kim JC, Yu CS, Park SH, Kim AY, Ha HK.
    Radiology; 2015 Mar 01; 274(3):712-22. PubMed ID: 25286324
    [Abstract] [Full Text] [Related]

  • 16. Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings.
    Huppertz A, Balzer T, Blakeborough A, Breuer J, Giovagnoni A, Heinz-Peer G, Laniado M, Manfredi RM, Mathieu DG, Mueller D, Reimer P, Robinson PJ, Strotzer M, Taupitz M, Vogl TJ, European EOB Study Group.
    Radiology; 2004 Jan 01; 230(1):266-75. PubMed ID: 14695400
    [Abstract] [Full Text] [Related]

  • 17. T2-weighted MR imaging in the assessment of cirrhotic liver.
    Hussain HK, Syed I, Nghiem HV, Johnson TD, Carlos RC, Weadock WJ, Francis IR.
    Radiology; 2004 Mar 01; 230(3):637-44. PubMed ID: 14739306
    [Abstract] [Full Text] [Related]

  • 18. Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma.
    Ahn SS, Kim MJ, Lim JS, Hong HS, Chung YE, Choi JY.
    Radiology; 2010 May 01; 255(2):459-66. PubMed ID: 20413759
    [Abstract] [Full Text] [Related]

  • 19. Diagnosis of focal liver lesions with gadoxetic acid-enhanced MRI: is a shortened delay time possible by adding diffusion-weighted imaging?
    Kim MY, Kim YK, Park HJ, Park MJ, Lee WJ, Choi D.
    J Magn Reson Imaging; 2014 Jan 01; 39(1):31-41. PubMed ID: 24115329
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings.
    Lee DH, Lee JM, Baek JH, Shin CI, Han JK, Choi BI.
    Radiology; 2015 Jan 01; 274(1):149-60. PubMed ID: 25203131
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.